Medical researchers are arming themselves with a new series of weapons in the war against diseases – conjugated drugs that link biological molecules to a highly potent active pharmaceutical ingredient (HPAPIs). Cynthia Wooge, SAFC® process development manager and a leading expert on conjugation technology gives us an overview of this new exciting technology where we could see some projects reach commercial scale within the next 1-4 years. Dr Wooge also discusses details of the current industry guidance about safely handling highly potent APIs.
|
|
Food & Beverage: Food & Beverage Development - Europe | Food & Beverage Development - North America | Food Marketing and Retailing | Food Processing & Packaging | Food Safety & Quality Control | Food and Beverage in Asia Pacific | Industrial Baking & Snacks | Beverage Technology & Markets | Confectionery & Biscuit Processing | Dairy Processing & Markets | Prepared Food and Meat Processing Nutrition: Supplements & Nutrition - Europe | Supplements & Nutrition - North America Pharmaceutical: Pharmaceutical Technology | Contract Research, Manufacturing & Clinical Trials Cosmetics: Cosmetics Formulation & Packaging - North America | Cosmetics Formulation & Packaging - Europe
